Hannah Dzimitrowicz McManus
@hannahdzmd
Followers
453
Following
2K
Media
11
Statuses
89
Genitourinary medical oncologist @DukeGUCancer
Durham, NC
Joined September 2018
RT @KidneyCancer: Federal #kidneycancer research funding drops from $50 million to ZERO after 57% cut to CDMRP. All but 12 of the 35 diseas….
0
19
0
RT @AarmstrongDuke: Great job @TiansterZhang discussing the moons of Jupiter and new advances in kidney cancer at #GU25 @ASCO ! https://t.c….
0
3
0
Come check out our latest work in @IRONMANregistry evaluating PSA nadir and relationship to disease relapse in mHSPC at poster B11 #GU25.
Hannah McManus presents update on IRONMAN registry data at #GU25. @hannahdzmd @DrPhilKantoff @DukeCancer
0
5
16
RT @TiansterZhang: Fantastic recognition for @Daniel_J_George @DukeGUCancer — recipient of this year’s Vogelzang humanitarian award!! @Matt….
0
4
0
RT @AarmstrongDuke: Check out our podcast on treatment sequencing in mCRPC with @hannahdzmd based on this @pcan_jou….
reachmd.com
Since there are multiple therapeutic options available for patients with metastatic castration-resistant prostate cancer (mCRPC), it’s important to balance efficacy, safety, and patient preferences...
0
4
0
Excited to share our new review on Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey. @AarmstrongDuke @CaPsurvivorship @TDorffOnc @sartor_oliver @nealshore @pcan_journal .
2
3
20
Thank you @GUconference for the opportunity to share our work in @IRONMANregistry demonstrating the ability to adapt guideline concordant care for #prostatecancer in the real world. Fantastic conference for learning, networking, and fun! @IDEOlogyHealth.
Great start to @GUconference with an interactive poster session. @hannahdzmd discussing high uptake of combined therapy for mHSPC in @IRONMANregistry @loreleimucci
0
1
18
RT @Daniel_J_George: Large @uk_biobank study confirmed many heritable gene-cancer associations. Shevach and @hannahdzmd explain how the new….
0
4
0
RT @DCockrellMD: Bittersweet last clinic day @UNCMedCenter after 10 years @UNC between college, residency, and fellowship. Seems like the r….
0
2
0
RT @TiansterZhang: The #WomeninOncology networking center has a wonderful line up at #ASCO24!. Privileged to join @KVanLoonMD @SuzanneColeM….
0
9
0
At #AACR2024 ? Come check out our poster examining uptake of guideline concordant mHSPC care in @IRONMANregistry . Rapid uptake of changing therapies and 86% rate overall📈. Important to develop quality benchmarks to ensure #prostatecancer patients getting best therapies.
0
2
11
RT @TumorBoardTues: 1/4 🚨 Time for a #TumorBoardTuesday extra! @AarmstrongDuke discusses developments w PARPi from #GU24:. - Sequence PARPi….
0
5
0
RT @AarmstrongDuke: Wondering what to offer your NEPC/small cell prostate cancer patient after platinum chemo? Clinical trials but also per….
0
5
0
RT @MattLabsMD: Awesome start to #GU24 sharing our clinical and implementation outcomes using pluvicto at @DukeGUCancer with rising ⭐️s Val….
0
3
0
Tune in and bring your questions tonight! Very excited to chat all things parp/arpi and #prostatecancer with @AarmstrongDuke Great way to start the week leading up to #GU24 @ASCO ! #bestweekever.
#TumorBoardTuesday.There have been so many changes in the management of #prostatecancer ‼️. 📢Join us Tonight, 01-23-2024 at🕰️8PM ET as @AarmstrongDuke and @hannahdzmd🗣️the use of PARP/ARPI combos in mCRPC. RT and bring others into the discussion‼️
0
5
17
RT @TumorBoardTues: @StefiMorganti @nlinmd @drsarahsam @DFCI_BreastOnc @stolaney1 @curijoey @PTarantinoMD @ASCO Join us next week, January….
0
3
0
Always a pleasure chatting with @AarmstrongDuke about how to improve care for our patients with #prostatecancer ! Check out this new podcast series discussing mHSPC.
Looking for a new podcast? Try our 3 part series podcast on mHSPC! Featuring @MattLabsMD @hannahdzmd and Ryan Fecteau offering perspectives on new therapies, disparities, and multi-D care. @DukeGUCancer @DukeCancer.
0
0
4
RT @Daniel_J_George: Microbiome metabolites associated with worse outcomes on immunotherapy in RCC pts. Thrilled to welcome @BariShahlaMD t….
0
11
0
RT @AarmstrongDuke: Love this team! @DukeGUCancer @TiansterZhang @Daniel_J_George @LandonBrownMD @hannahdzmd @TheRealJasonZhu #ASCO23 what….
0
2
0
RT @TiansterZhang: The best kind of day in #oncology — spend it with your tribe. Loved seeing @LandonBrownMD @hannahdzmd @TheRealJasonZhu @….
0
1
0